tolvaptan has been researched along with cyc 202 in 1 studies
Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) |
---|---|---|---|---|---|
967 | 172 | 786 | 979 | 7 | 393 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, MY; Ong, AC | 1 |
1 review(s) available for tolvaptan and cyc 202
Article | Year |
---|---|
Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects.
Topics: Aniline Compounds; Antihypertensive Agents; Benzazepines; Clinical Trials as Topic; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Depression, Chemical; Disease Management; Double-Blind Method; Drugs, Investigational; Forecasting; Histone Deacetylase Inhibitors; Humans; Multicenter Studies as Topic; Nitriles; Polycystic Kidney, Autosomal Dominant; Purines; Quinolines; Randomized Controlled Trials as Topic; Roscovitine; Signal Transduction; Somatostatin; Tolvaptan; TOR Serine-Threonine Kinases; Translational Research, Biomedical | 2012 |